The Lead Episode 121: A Discussion of Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia, LIVE at HRX

Discussion Topic: Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia

Join Digital Education Committee host Jason Jacobson, MD, FHRS, as he discusses this late 2024 article with guests Miguel Valderrabano, MD, PhD, FHRS and J. Peter Weiss, MD, Msci, FHRS, from the HRSTv Studio in Atlanta at HRX 2025.

The trial compared two treatment strategies for patients with ventricular tachycardia: early catheter ablation versus continuing antiarrhythmic drug therapy (mostly sotalol or amiodarone).

It found that starting with catheter ablation resulted in fewer episodes of ventricular tachycardia, less need for hospitalizations and interventions, and better overall control of arrhythmias compared to relying on drugs alone.

Host: Jason Jacobson, MD, FHRS

Guests: Miguel Valderrabano, MD, PhD, FHRS and J. Peter Weiss, MD, Msci, FHRS

Speaker and Article Information: Download

Listen on Heart Rhythm 365
Listen on the Innovation Hub
Listen on Apple Podcasts
Listen on iHeart
Listen on Spotify